Fiduciary Family Office’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Sell
14,960
-453
-3% -$106K 0.95% 17
2026
Q1
$3.77M Buy
15,413
+6,106
+66% +$1.42M 1.07% 13
2025
Q4
$1.93M Sell
9,307
-628
-6% -$124K 0.55% 34
2025
Q3
$1.84M Sell
9,935
-266
-3% -$45.6K 0.52% 36
2025
Q2
$1.56M Buy
10,201
+1,109
+12% +$170K 0.51% 37
2025
Q1
$1.51M Buy
+9,092
New +$1.42M 0.5% 36
2024
Q4
Sell
-9,654
Closed -$1.56M 166
2024
Q3
$1.56M Buy
9,654
+1,004
+12% +$160K 0.52% 40
2024
Q2
$1.26M Sell
8,650
-1,576
-15% -$234K 0.5% 47
2024
Q1
$1.62M Sell
10,226
-155
-1% -$24.7K 0.63% 39
2023
Q4
$1.63M Buy
+10,381
New +$1.59M 0.71% 25

Other funds holding JNJ

Fiduciary Family Office's JNJ Position: Q2 2026 in Review

Fiduciary Family Office reduced its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2026, selling an estimated $106K and leaving 14,960 shares worth $3.8M. The position accounts for 0.95% of the portfolio, ranked #17.

Fiduciary Family Office first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Fiduciary Family Office held 14,960 shares of Johnson & Johnson worth $3.8M as of Q2 2026.
  • Fiduciary Family Office sold 453 Johnson & Johnson shares in Q2 2026, an estimated $106K.
  • Johnson & Johnson made up 0.95% of Fiduciary Family Office's portfolio in Q2 2026, its #17 holding.
  • Fiduciary Family Office first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.